| TED | Tasks of Emotional Development; threshold erythema dose; thromboembolic disease |
|---|---|
| A&P | anterior and posterior; assessment and plans; auscultation and percussion |
| C&P | compensation and pension; complete and pain free [joint movement]; cystoscopy and pyelography |
| C&S | calvarium and scalp; conjunctiva and sclera; culture and sensitivity |
| DRIP | delirium and drugs-restricted mobility and retention-infection, inflammation and impaction-polyuria ... |
| health care quality, access, and evaluation | The concept concerned with all aspects of the quality, accessibility, and appraisal of health care and health care delivery. (12 Dec 1998) |
|---|---|
| primary hyperoxaluria and oxalosis | A metabolic disorder characterised by calcium oxalate nephrocalcinosis and nephrolithiasis, extrarenal oxalosis, and increased urinary output of oxalic and glycolic acids; usually evident clinically in the first decade of life, with progressive renal failure and uraemia; autosomal recessive inheritance. Type I is due to an alteration in alanine:glyoxylate aminotransferase; type II is due to an alteration in d-glycerate dehydrogenase. (05 Mar 2000) |
| health services needs and demand | Health services required by a population or community as well as the health services that the population or community is able and willing to pay for. It includes the identification and assessment of the needs as measured by objective criteria and standards. (12 Dec 1998) |
| heart and lung transplant | A surgical procedure which replaces a diseased heart and lungs with a healthy heart and lungs from a donor. They have been used in patients with primary pulmonary hypertension and isolated severe heart and lung disease. They are not recommended for those with associated systemic disorders such as diabetes or autoimmune illness. Those with liver and/or kidney disease are also not candidates. Long-term outcomes are still being studied. (27 Sep 1997) |
| saint kitts and nevis | An independent federation of the leeward islands in the west indies, consisting of saint christopher, nevis, and sombrero. Its capital is basseterre. It was discovered by columbus in 1493, settled by the british in 1625, the first of the leeward islands to be colonised by them. It was held jointly by the french and english 1628-1713, but returned to great britain by the treaty of utrecht in 1713. It was held by the french 1782-83. Under the british for the next 200 years, it gained its independence in 1983. (12 Dec 1998) |
| saint vincent and the grenadines | A self-governing state of the windward islands in the west indies, comprising saint vincent and the northern islets of the grenadines. Its capital is kingstown. It is one of the original homes of the carib indians supposed to have been sighted by columbus in 1498. It was in english hands from 1627 till held by the french 1779-83. Saint vincent subsequently became a british possession and, with other nearby british territories, was administered by the governor of the windward islands till 1959. It attained a measure of independence in 1969 but achieved full independence as saint vincent and the grenadines in 1979. Saint vincent was the 4th century spanish martyr on whose feast day columbus discovered the island. Grenadines is derived from the spanish kingdom of granada. (12 Dec 1998) |
| salaries and fringe benefits | The remuneration paid or benefits granted to an employee. (12 Dec 1998) |
| hemic and immune systems | The organs involved in the production and functions of the blood and the cellular and molecular components providing defense against foreign organisms or substances. (12 Dec 1998) |
| hemic and lymphatic diseases | Haematologic diseases and diseases of the lymphatic system collectively. Hemic diseases include disorders involving the formed elements (e.g., erythrocyte aggregation, intravascular) and chemical components (e.g., blood protein disorders); lymphatic diseases include disorders relating to lymph, lymph nodes, and lymphocytes. (12 Dec 1998) |
| hepatitis d, e, f, and g | Lesser known (than hepatitis a, b, and c), the most significant of these seems to be type d, or the delta agent, which only causes disease in the presence of the hepatitis b virus. (12 Dec 1998) |
| hereditary deafness and nephropathy | <nephrology, pathology> An inherited disorder involving damage to the kidneys, haematuria and hearing loss. In some individuals vision may also be affected. This genetic disease is uncommon. Symptoms include loss of hearing, abnormal colour to urine, swelling, cough and decline in vision. Inheritance: sex-linked autosomal dominant. Incidence: 1 in 50,000. Origin: Gr. Pathos = disease (27 Sep 1997) |
| prostheses and implants | Artificial substitutes for body parts, and materials inserted into tissue for functional, cosmetic, or therapeutic purposes. Prostheses can be functional, as in the case of artificial arms and legs, or cosmetic, as in the case of an artificial eye. Implants, all surgically inserted or grafted into the body, tend to be used therapeutically. Implants, experimental is available for those used experimentally. (12 Dec 1998) |
| prothrombin and proconvertin test | A test formerly used by some to control anticoagulant therapy with bishydroxycoumarin and indandione drugs. Synonym: P and P test. (05 Mar 2000) |
| schizophrenia and disorders with psychotic features | Marked disorders of thought (delusions, hallucinations, or other thought disorder accompanied by disordered affect or behaviour), and deterioration from a previous level of functioning. (12 Dec 1998) |
| protoveratrine A and B | A mixture of two alkaloids isolated from Veratrum album; they exert their main effect upon the cardiovascular system through the carotid sinus receptors and vagal sensory endings in the heart; they cause vasodilation and are thought to bring about a redistribution to all vascular beds and thus to induce a fall in blood pressure; used in certain forms of hypertension; the maleates have the same actions. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|